NSD3 and lung adenocarcinoma: In summary, our studies explore the vital role of NSD3 non‐epigenetic regulatory effects in lung adenocarcinoma progression and metabolism, indicating that NSD3 as a promising therapeutic target for lung adenocarcinoma.